Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals

Chronic hepatitis C virus (HCV) infection is associated with an increased risk of extrahepatic cancers, particularly non-Hodgkin lymphoma. The introduction of direct-acting antivirals (DAAs) has revolutionized HCV therapy, resulting in high cure rates. However, concerns have been raised about potent...

Full description

Bibliographic Details

Main Authors:	Joji Tani, Tsutomu Masaki, Kyoko Oura, Tomoko Tadokoro, Asahiro Morishita, Hideki Kobara
Format:	Artigo
Language:	Inglês
Published:	MDPI AG 2024-09-01
Series:	Microorganisms
Subjects:	hepatitis C virus direct-acting antivirals extrahepatic cancer sustained virologic response
Online Access:	https://www.mdpi.com/2076-2607/12/9/1926
Tags:	Add Tag No Tags, Be the first to tag this record!